Appropriate patients.

Indicated for KidneyIntelX Not Indicated for KidneyIntelX
KidneyIntelX is indicated for use as an aid to further assess the risk of progressive decline in kidney function within a period of up to 5 years in patients over the age of 21 with type 2 diabetes and existing chronic kidney disease
Patients with chronic kidney disease who have an estimated Glomerular Filtration Rate [eGFR] of 30-59 ml/min/1.73m2 [G3a, G3b] or an eGFR ≥ 60 with albuminuria [UACR] ≥ 30 mg/g. [A2, A3]
Diabetic patients who have not yet been diagnosed with chronic kidney disease
Patients who are taking ENBREL
Indicated for KidneyIntelX
KidneyIntelX is indicated for use as an aid to further assess the risk of progressive decline in kidney function within a period of up to 5 years in patients over the age of 21 with Type 2 diabetes and existing chronic kidney disease.
Patients with chronic kidney disease who have an estimated Glomerular Filtration Rate [eGFR] of 30-59 ml/min/1.73 m2 [G3a, G3b] or an eGFR ≥ 60 with albuminuria [UACR] ≥ 30 mg/g. [A2, A3].
Not indicated for KidneyIntelX
Diabetic patients who have not yet been diagnosed with chronic kidney disease.
Patients who are taking ENBREL.
Order Test
About Test
See Evidence
Client Service Team
Clinician FAQs